SPECTROFLOW

In 2020, SpectroFlow conducted a survey of 145 LE patients in the US and UK. 64% of the patients surveyed thought about LE once a week or more. Roughly half of that same group of patients reported seeing their clinician annually or less... SpectroFlow has developed a unique non-invasive technology for measuring fluid variation with a mindset that patient compliance would be our highest priority in product development... In 2020, via National Lymphedema Network, SpectroFlow conducted a survey of 50 healthcare professionals with a lymphedema diagnosis and/or management care focus.

Also known as: SpectroFlow Corp

Primary location: Nokomis United States